BRPI1008167A2 - mutantes de mcp-1 antagonizando glicosaminoglicano e método de usar os mesmos - Google Patents
mutantes de mcp-1 antagonizando glicosaminoglicano e método de usar os mesmosInfo
- Publication number
- BRPI1008167A2 BRPI1008167A2 BRPI1008167A BRPI1008167A BRPI1008167A2 BR PI1008167 A2 BRPI1008167 A2 BR PI1008167A2 BR PI1008167 A BRPI1008167 A BR PI1008167A BR PI1008167 A BRPI1008167 A BR PI1008167A BR PI1008167 A2 BRPI1008167 A2 BR PI1008167A2
- Authority
- BR
- Brazil
- Prior art keywords
- glycosaminoglycan
- antagonizing
- mcp
- mutants
- mutants antagonizing
- Prior art date
Links
- 101100504320 Caenorhabditis elegans mcp-1 gene Proteins 0.000 title 1
- 229920002683 Glycosaminoglycan Polymers 0.000 title 1
- 230000003042 antagnostic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14876609P | 2009-01-30 | 2009-01-30 | |
| EP09166429 | 2009-07-27 | ||
| PCT/EP2010/051128 WO2010086426A1 (en) | 2009-01-30 | 2010-01-29 | Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008167A2 true BRPI1008167A2 (pt) | 2016-03-29 |
Family
ID=41323633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008167A BRPI1008167A2 (pt) | 2009-01-30 | 2010-01-29 | mutantes de mcp-1 antagonizando glicosaminoglicano e método de usar os mesmos |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120046218A1 (pt) |
| EP (1) | EP2391645A1 (pt) |
| JP (1) | JP2012516143A (pt) |
| CN (1) | CN102378765A (pt) |
| BR (1) | BRPI1008167A2 (pt) |
| CA (1) | CA2750983A1 (pt) |
| EA (1) | EA201101131A1 (pt) |
| WO (1) | WO2010086426A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015110526A1 (en) * | 2014-01-22 | 2015-07-30 | Antagonis Biotherapeutics Gmbh | Novel glycosaminoglycan-antagonising fusion proteins and methods of using same |
| CN110538327B (zh) * | 2017-08-21 | 2021-08-03 | 武汉大学 | Gpr31抑制剂在制备治疗脂肪代谢异常及相关疾病的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001089582A1 (en) * | 2000-05-26 | 2001-11-29 | Takeda Chemical Industries, Ltd. | Preventives and remedies for pulmonary hypertension |
| CN1665839A (zh) | 2002-04-10 | 2005-09-07 | 应用研究系统Ars股份公司 | Mcp蛋白质的新型拮抗剂 |
| AR046594A1 (es) * | 2003-10-16 | 2005-12-14 | Applied Research Systems | Usos terapeuticos de variantes de quemoquina |
| AT412785B (de) | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| EP2042516A1 (en) * | 2007-09-27 | 2009-04-01 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
-
2010
- 2010-01-29 WO PCT/EP2010/051128 patent/WO2010086426A1/en not_active Ceased
- 2010-01-29 CA CA2750983A patent/CA2750983A1/en not_active Abandoned
- 2010-01-29 EP EP10701390A patent/EP2391645A1/en not_active Withdrawn
- 2010-01-29 EA EA201101131A patent/EA201101131A1/ru unknown
- 2010-01-29 BR BRPI1008167A patent/BRPI1008167A2/pt not_active IP Right Cessation
- 2010-01-29 CN CN2010800144455A patent/CN102378765A/zh active Pending
- 2010-01-29 JP JP2011546862A patent/JP2012516143A/ja not_active Withdrawn
- 2010-01-29 US US13/145,217 patent/US20120046218A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA201101131A1 (ru) | 2012-01-30 |
| CN102378765A (zh) | 2012-03-14 |
| WO2010086426A1 (en) | 2010-08-05 |
| US20120046218A1 (en) | 2012-02-23 |
| EP2391645A1 (en) | 2011-12-07 |
| CA2750983A1 (en) | 2010-08-05 |
| JP2012516143A (ja) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0922248A2 (pt) | eletrodo e método de produção do mesmo | |
| BRPI1015350A2 (pt) | anticorpos de anti-ceacam1 e métodos de usar os mesmos | |
| PL2427212T3 (pl) | Przeciwciała anty cd-100 i sposoby ich zastosowania | |
| BR112012013955A2 (pt) | método de preparação de um derivado oxidado de ácido hialurônico e método de modificação do derivado de ácido hialurônico | |
| SMT201600075B (it) | Composto di diamminocarbossammide eterociclica | |
| BR112012013954A2 (pt) | derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico | |
| EP2496176A4 (en) | ENTZELLULARISIERUNGSVERFAHREN | |
| BR112013029457A2 (pt) | método de fracionamento e pirólise rápida de biomassa integrada | |
| BRPI1006830A2 (pt) | composições de leveduras entrelaçadas com argila e método de utilização das mesmas | |
| EP2508600A4 (en) | MUTANT ENZYM AND ITS APPLICATION | |
| EP2414387A4 (en) | Compositions and methods related to protein a (spa) variants | |
| BRPI0916568A2 (pt) | método de produção de particulas de polissacarídeo reticuladas | |
| LT2494039T (lt) | Ląstelių perprogramavimo būdai ir jų panaudojimas | |
| GB201120615D0 (en) | Optical sensor and method of use | |
| LT3156075T (lt) | Oligosacharidas ir jo paruošimo būdas | |
| BRPI1009989A2 (pt) | "método de produção de viga de torção e viga de torção" | |
| EP2467914A4 (en) | SLEEVE SYSTEM AND METHOD FOR USE THEREOF | |
| IT1395088B1 (it) | Veicolo battipista e metodo di controllo dello stesso | |
| DK2517482T3 (da) | Metode til betjening af høreapparat samt et høreapparat | |
| EP2451391A4 (en) | HIP JOINING DEVICE AND METHOD THEREFOR | |
| IL218474A0 (en) | Novel fusion proteins and method of expression thereof | |
| EP2451392A4 (en) | HIP JOINING DEVICE AND METHOD THEREFOR | |
| BRPI1012081A2 (pt) | processo e instalção de construção de uma aeronave | |
| EP2189476A4 (en) | NOVEL POLYPEPTIDE AND MANUFACTURING METHOD THEREFOR | |
| EP2519113A4 (en) | HARD AND CRISPY SWEET CARE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |